These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24533944)

  • 1. MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.
    Lund H; Gustafsson E; Svensson A; Nilsson M; Berg M; Sunnemark D; von Euler G
    Acta Neuropathol Commun; 2014 Feb; 2():22. PubMed ID: 24533944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
    Lagalwar S; Berry RW; Binder LI
    Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
    Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
    Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.
    Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K
    J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders.
    Yamazaki Y; Matsubara T; Takahashi T; Kurashige T; Dohi E; Hiji M; Nagano Y; Yamawaki T; Matsumoto M
    PLoS One; 2011; 6(11):e26996. PubMed ID: 22073234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal CA1 neurons in Alzheimer's disease and Pick's disease: a lesion distinct from granulovacuolar degeneration.
    Probst A; Herzig MC; Mistl C; Ipsen S; Tolnay M
    Acta Neuropathol; 2001 Dec; 102(6):636-44. PubMed ID: 11761725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated NF-κB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy.
    Yamaguchi Y; Ayaki T; Li F; Tsujimura A; Kamada M; Ito H; Maki T; Sawamoto N; Urushitani M; Takahashi R
    Neurosci Lett; 2019 Jun; 704():229-235. PubMed ID: 30946927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease.
    Gu GJ; Wu D; Lund H; Sunnemark D; Kvist AJ; Milner R; Eckersley S; Nilsson LN; Agerman K; Landegren U; Kamali-Moghaddam M
    J Alzheimers Dis; 2013; 33(3):699-713. PubMed ID: 23001711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.
    Gu GJ; Lund H; Wu D; Blokzijl A; Classon C; von Euler G; Landegren U; Sunnemark D; Kamali-Moghaddam M
    Neuromolecular Med; 2013 Sep; 15(3):458-69. PubMed ID: 23666762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules.
    Ikegami K; Kimura T; Katsuragi S; Ono T; Yamamoto H; Miyamoto E; Miyakawa T
    Psychiatry Clin Neurosci; 1996 Jun; 50(3):137-40. PubMed ID: 9201760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
    Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
    PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule-affinity regulating kinase family members distinctively affect tau phosphorylation and promote its toxicity in a Drosophila model.
    Sultanakhmetov G; Kato I; Asada A; Saito T; Ando K
    Genes Cells; 2024 Apr; 29(4):337-346. PubMed ID: 38329182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is granulovacuolar degeneration an essential pathological component of Alzheimer's disease? A review of the pathogenesis and histochemistry of old studies.
    Kurdi M; Alghamdi B
    Folia Neuropathol; 2020; 58(4):277-286. PubMed ID: 33480232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment.
    Sun W; Lee S; Huang X; Liu S; Inayathullah M; Kim KM; Tang H; Ashford JW; Rajadas J
    Sci Rep; 2016 Oct; 6():34784. PubMed ID: 27708431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology.
    Köhler C
    Acta Neuropathol; 2016 Sep; 132(3):339-59. PubMed ID: 27062260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
    Trinczek B; Brajenovic M; Ebneth A; Drewes G
    J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
    Bondareff W; Wischik CM; Novak M; Roth M
    Am J Pathol; 1991 Sep; 139(3):641-7. PubMed ID: 1909492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B).
    Midani-Kurçak JS; Dinekov M; Puladi B; Arzberger T; Köhler C
    Brain Res; 2019 Mar; 1706():224-236. PubMed ID: 30414727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.